Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Cancer Prevention Month: Get ACRO Health Gift Cards! Cancer Prevention Month: Get ACRO Health Gift Cards!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Captured Human TSLP (R127A, R130A), His Tag (Cat. No. TSP-H52Ha) on CM5 Chip via anti-His antibody, can bind Human TSLP R, Fc Tag (Cat. No. TSR-H525a) with an affinity constant of 4.22 nM as determined in SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Tezepelumab | AMG-157; MEDI-9929 | Approved | Amgen Inc | Tezspire | United States | Asthma | Astrazeneca Ab | 2021-12-17 | Eosinophilic Esophagitis; Hypersensitivity; Dermatitis, Atopic; Hypersensitivity, Immediate; Bronchial Diseases; Pulmonary Disease, Chronic Obstructive; Sinusitis; Respiratory Hypersensitivity; Asthma; Lung Diseases, Obstructive; Immune System Diseases; Lung Diseases; Respiratory Tract Diseases; Nasal Polyps; Nose Diseases; Chronic Urticaria; Carcinoma; Anaphylaxis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
HBM-9378 | SKB378; HBM-9378 | Phase 1 Clinical | Harbour Biomed, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | Asthma | Details |
WIN-1001X | WIN-1001X | Phase 2 Clinical | Whanin Pharmaceutical Co Ltd | Nerve Degeneration; Parkinson Disease | Details |
GR2002 | GR2002 | Phase 1 Clinical | Nasal Polyps; Asthma; Sinusitis; Dermatitis, Atopic | Details | |
BSI-045B | BSI-045B; TQC-2731; TQC2731 | Phase 2 Clinical | Biosion Inc | Nasal Polyps; Sinusitis; Asthma; Dermatitis, Atopic | Details |
CM-326(Connaught Biomedical Technology) | CM-326 | Phase 2 Clinical | Keymed Biosciences Co Ltd | Nasal Polyps; Nose Diseases; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
AZD-8630 | AZD-8630; AMG-104 | Phase 1 Clinical | Astrazeneca Plc, Amgen Inc | Asthma | Details |
STSA-1201 | STSA-1201; STSA1201 | Phase 1 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Asthma | Details |
PF-06342674 | RN-168; PF-6342674; PF-06342674; ZB-168 | Phase 1 Clinical | Pfizer Inc | Diabetes Mellitus, Type 1; Multiple Sclerosis | Details |
SHR-1905 | SHR-1905; AIO-001 | Phase 2 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | Nasal Polyps; Nose Diseases; Respiratory Tract Diseases; Sinusitis; Asthma | Details |
Ecleralimab | CSJ-117; NOV-14 | Phase 2 Clinical | Novartis Pharma Ag | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
LQ043H | LQ043H | Phase 1 Clinical | Shanghai Novamab Biopharmaceuticals Co Ltd | Asthma | Details |
PF-07275315 | PF-07275315 | Phase 2 Clinical | Pfizer Inc | Dermatitis, Atopic | Details |
GR-1802 | GR-1802 | Phase 3 Clinical | Nose Diseases; Chronic Urticaria; Nasal Polyps; Asthma; Sinusitis; Dermatitis, Atopic | Details | |
Lunsekimig | SAR-443765 | Phase 2 Clinical | Sanofi | Asthma; Inflammation | Details |
QX-008N | QX008N; QX-008N | Phase 1 Clinical | Qyuns Therapeutics Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
BD-9 | BD-9 | Biolojic Design Inc | Details |
This web search service is supported by Google Inc.